Today: 7 February 2026
Subscribe
Browse Category

Investment News News 28 January 2026 - 29 January 2026

Micron stock price jumps after-hours as $24 billion Singapore fab plan fuels MU rally

Micron stock price jumps after-hours as $24 billion Singapore fab plan fuels MU rally

Micron shares jumped 6.1% to $435.28 in after-hours trading Wednesday after the company confirmed a $24 billion wafer fab expansion in Singapore, with NAND production set for 2028. The move comes as chipmakers rally on strong tech earnings and a steady Fed, while investors weigh persistent supply constraints and intensifying competition from Samsung and SK Hynix.
29 January 2026
····
NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand

NextEra Energy stock price today: NEE steadies near a 52-week high as investors parse earnings, data-center demand

NextEra Energy shares rose 0.3% to $87.44 Wednesday afternoon after reporting 2025 adjusted earnings of $3.71 per share, up 8% from 2024. Executives said they are in advanced talks to supply 9 GW of data-center power in Florida and plan to add 6 GW of new nuclear capacity. Trading volume topped 5.7 million shares. Mizuho raised its price target to $90.
28 January 2026
·····
Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings

Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings

Bloom Energy shares surged 9.6% to $166.94 Wednesday, with volume topping 10.7 million after Baird raised its price target and Barclays began coverage. The rally follows a $2.65 billion fuel-cell deal with American Electric Power. Investors await Bloom’s Feb. 5 earnings for updates on production capacity and data-center demand. Plug Power and FuelCell Energy also posted gains.
28 January 2026
·····
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
28 January 2026
·····
F5 (FFIV) stock price jumps about 8% after forecast hike and Q1 earnings beat

F5 (FFIV) stock price jumps about 8% after forecast hike and Q1 earnings beat

F5 shares rose 8.5% to $293.37 after the company reported first-quarter revenue of $822 million, up 7% year over year, with systems sales surging 37%. Adjusted earnings per share reached $4.45, compared to $3.84 a year ago. F5 raised its fiscal 2026 revenue growth forecast to 5%-6% and projected second-quarter revenue between $770 million and $790 million.
28 January 2026
·····
Newmont stock rises as gold breaks $5,300 — Fed signal and new targets set the tone

Newmont stock rises as gold breaks $5,300 — Fed signal and new targets set the tone

Newmont shares rose 1.5% to $128.93 Wednesday as gold hit a record $5,311.31 an ounce before easing. The Federal Reserve held rates steady, keeping the dollar firm against the euro and yen. BMO and Scotiabank raised Newmont price targets to $145 and $152, respectively. Newmont will report full-year and Q4 results on Feb. 19.
28 January 2026
·····
Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson shares rose 1.2% to $227.06 after the FDA approved Darzalex Faspro for use with the VRd regimen in newly diagnosed multiple myeloma patients ineligible for stem cell transplant. The approval is based on the CEPHEUS trial, which showed improved outcomes. The move comes as Medicare named 15 drugs for future price negotiations, pressuring the sector.
28 January 2026
····
Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories shares fell about 2% to $106.12 Wednesday after Argus cut its price target to $140, following last week’s earnings warning. CEO Robert Ford bought 18,800 shares on Jan. 23 at an average $107.13, according to an SEC filing. The broader healthcare sector slipped ahead of the Federal Reserve’s rate decision. Abbott cited weak nutrition and diagnostics sales and higher costs for its recent profit miss.
28 January 2026
···
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
28 January 2026
·····
Energy Fuels stock price jumps nearly 11% on Roth upgrade as uranium spot hits $91 — traders watch what comes next

Energy Fuels stock price jumps nearly 11% on Roth upgrade as uranium spot hits $91 — traders watch what comes next

Energy Fuels Inc. surged 10.7% to $26.74 after Roth MKM upgraded the stock and uranium prices hit $91.10 a pound. The company disclosed terms of its planned A$447 million takeover of Australian Strategic Materials, targeting a June 2026 close. Trading volume reached 12.8 million shares by early afternoon. Energy Fuels will report earnings around Feb. 25.
28 January 2026
·····
Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet shares jumped 11% to $58.65 by early afternoon Wednesday after quarterly earnings and a third-quarter forecast topped Wall Street estimates. The company reported fiscal Q2 sales of $6.319 billion and adjusted EPS of $1.05, beating analyst expectations. Arrow Electronics and TD SYNNEX also rose. Avnet projected Q3 sales of $6.20–$6.50 billion and adjusted EPS of $1.20–$1.30.
28 January 2026
····
1 … 31 32 33 34 35 … 214

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop